Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP534263.RA4HklwlnSIMzBychCHDYTvoWp8xObkQaHJ6fMr6Uz8LI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP534263.RA4HklwlnSIMzBychCHDYTvoWp8xObkQaHJ6fMr6Uz8LI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP534263.RA4HklwlnSIMzBychCHDYTvoWp8xObkQaHJ6fMr6Uz8LI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP534263.RA4HklwlnSIMzBychCHDYTvoWp8xObkQaHJ6fMr6Uz8LI130_provenance.
- NP534263.RA4HklwlnSIMzBychCHDYTvoWp8xObkQaHJ6fMr6Uz8LI130_assertion description "[In this report, we explore the impact of the p38 activating, FDA-approved, blood brain barrier permeating compound celecoxib on SMN levels in vitro and in a mouse model of SMA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP534263.RA4HklwlnSIMzBychCHDYTvoWp8xObkQaHJ6fMr6Uz8LI130_provenance.
- NP534263.RA4HklwlnSIMzBychCHDYTvoWp8xObkQaHJ6fMr6Uz8LI130_assertion evidence source_evidence_literature NP534263.RA4HklwlnSIMzBychCHDYTvoWp8xObkQaHJ6fMr6Uz8LI130_provenance.
- NP534263.RA4HklwlnSIMzBychCHDYTvoWp8xObkQaHJ6fMr6Uz8LI130_assertion SIO_000772 23656793 NP534263.RA4HklwlnSIMzBychCHDYTvoWp8xObkQaHJ6fMr6Uz8LI130_provenance.
- NP534263.RA4HklwlnSIMzBychCHDYTvoWp8xObkQaHJ6fMr6Uz8LI130_assertion wasDerivedFrom befree-20140225 NP534263.RA4HklwlnSIMzBychCHDYTvoWp8xObkQaHJ6fMr6Uz8LI130_provenance.
- NP534263.RA4HklwlnSIMzBychCHDYTvoWp8xObkQaHJ6fMr6Uz8LI130_assertion wasGeneratedBy ECO_0000203 NP534263.RA4HklwlnSIMzBychCHDYTvoWp8xObkQaHJ6fMr6Uz8LI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP534263.RA4HklwlnSIMzBychCHDYTvoWp8xObkQaHJ6fMr6Uz8LI130_provenance.